Pacific Biosciences of California, Inc. (FRA:P09)

FRA:P09 Statistics

Total Valuation

FRA:P09 has a market cap or net worth of EUR 579.13 million. The enterprise value is 927.02 million.

Market Cap	579.13M
Enterprise Value	927.02M

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	301.91M
Shares Outstanding	n/a
Shares Change (YoY)	+9.13%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	0.74%
Owned by Institutions (%)	60.20%
Float	299.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.40
PB Ratio	18.83
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.16
EV / Sales	6.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.61

Financial Position

The company has a current ratio of 6.24, with a Debt / Equity ratio of 19.48.

Current Ratio	6.24
Quick Ratio	5.21
Debt / Equity	19.48
Debt / EBITDA	n/a
Debt / FCF	-5.57
Interest Coverage	-72.89

Financial Efficiency

Return on equity (ROE) is -205.90% and return on invested capital (ROIC) is -34.37%.

Return on Equity (ROE)	-205.90%
Return on Assets (ROA)	-32.23%
Return on Invested Capital (ROIC)	-34.37%
Return on Capital Employed (ROCE)	-78.52%
Revenue Per Employee	229,134
Profits Per Employee	-746,517
Employee Count	575
Asset Turnover	0.14
Inventory Turnover	1.62

Taxes

In the past 12 months, FRA:P09 has paid 368,194 in taxes.

Income Tax	368,194
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.95% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+29.95%
50-Day Moving Average	1.41
200-Day Moving Average	1.46
Relative Strength Index (RSI)	60.24
Average Volume (20 Days)	4,629

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.86

Income Statement

In the last 12 months, FRA:P09 had revenue of EUR 131.75 million and -429.25 million in losses. Loss per share was -1.45.

Revenue	131.75M
Gross Profit	49.75M
Operating Income	-495.16M
Pretax Income	-428.88M
Net Income	-429.25M
EBITDA	-164.15M
EBIT	-495.16M
Loss Per Share	-1.45

Balance Sheet

The company has 254.54 million in cash and 599.24 million in debt, giving a net cash position of -344.69 million.

Cash & Cash Equivalents	254.54M
Total Debt	599.24M
Net Cash	-344.69M
Net Cash Per Share	n/a
Equity (Book Value)	30.76M
Book Value Per Share	0.10
Working Capital	282.13M

Cash Flow

In the last 12 months, operating cash flow was -104.65 million and capital expenditures -2.96 million, giving a free cash flow of -107.61 million.

Operating Cash Flow	-104.65M
Capital Expenditures	-2.96M
Free Cash Flow	-107.61M
FCF Per Share	n/a

Margins

Gross Margin	37.76%
Operating Margin	-375.83%
Pretax Margin	-325.52%
Profit Margin	n/a
EBITDA Margin	-124.59%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:P09 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.13%
Shareholder Yield	-9.13%
Earnings Yield	-74.12%
FCF Yield	-18.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:P09 has an Altman Z-Score of -5.98 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.98
Piotroski F-Score	4